Boundless Bio (NASDAQ:BOLD) reported a fourth-quarter loss of $0.58 per share, beating analyst expectations for a loss of ...

Boundless announced the following updates to its portfolio of novel ecDTx programs for a range of aggressive and difficult-to-treat cancer indications: Initial clinical data readout for BBI-355 on ...

Seattle-based startup Boundless laid off four employees and asked 27 workers to relocate to Las Vegas as part of what CEO Xiao Wang described as a restructuring. The online immigration service in ...

Boundless Bio has announced a strategic portfolio prioritization aimed at optimizing its oncology programs, particularly focusing on the combination therapy of BBI-355 and BBI-825, alongside a new ...

Boundless Bio, the precision oncology company working on treatments for oncogene-amplified cancers, is amping up its fundraising with a new $100 million series C round backed by Leaps by Bayer and RA ...

Texas-based company Monumental announced it’s acquired Boundless, an MMO from developer Turbulenz. The development studio will partner with Turbulenz on future development of the open-world sandbox ...

Our education system is broken, from lower-level public schools all the way up to higher learning. EdTech startups are coming at the numerous problems from every angle. Boundless, a startup out of ...